Untreated Adult Acute Myeloid Leukemia Completed Phase 1 Trials for Daunorubicin (DB00694)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02323607Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 MutationsTreatment
NCT00039117Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid LeukemiaTreatment